Home › Atrial Fibrillation › Tennessee › Memphis
Atrial Fibrillation clinical trials in Memphis, TN
3 studies for Atrial Fibrillation are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Fourth Left Atrial Appendage Occlusion Study
Recruiting
- The University of Tennessee, Memphis
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
RecruitingPhase 3
- Anthos Investigative Site 1056, Memphis
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
RecruitingPhase 3
- Methodist University Hospital, Memphis
- Semmes Murphey Main Campus, Memphis
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- New York City, NY21 studies
- Boston, MA17 studies
- Cleveland, OH17 studies
- Atlanta, GA16 studies
- Philadelphia, PA12 studies
- Jonesboro, AR12 studies
- Chicago, IL12 studies
- Ann Arbor, MI11 studies
- Pittsburgh, PA10 studies
- Columbus, OH10 studies
- Cincinnati, OH10 studies
- Austin, TX9 studies
Other studies in Memphis
- Cancer (all types)31 studies
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer22 studies
- Lung Cancer18 studies
- Sickle Cell Disease18 studies
- Acute Lymphoblastic Leukemia16 studies
- Acute Myeloid Leukemia15 studies
- Heart Failure13 studies
- Colorectal Cancer11 studies
- Soft Tissue Sarcoma11 studies
- Melanoma11 studies
- Prostate Cancer11 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.